Showing results (271-280 of 676) with videos related to

Sort By:
Pageof 68
Agents and Actions|December 1, 1980
Slow-reacting substances and their formation by a lipoxygenase pathwayP J Piper, M N Samhoun, J R Tippins, et al.
Ciba Foundation Symposium|January 1, 1980
Slow-reacting substances and their structural elucidationP J Piper, M N Samhoun, J R Tippins, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 5, 2007
Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopramBrian J Piper, Joseph B Fraiman, Cullen B Owens, et al.
Frontiers in Psychiatry|March 20, 2025
Patterns in (es)citalopram prescriptions to Medicaid and Medicare patients in the United States: the potential effects of evergreeningLuke R Cavanah, Parita K Ray, Jessica L Goldhirsh, et al.
BMJ Open|March 7, 2024
State-level variation in distribution of oxycodone and opioid-related deaths from 2000 to 2021: an ecological study of ARCOS and CDC WONDER data in the USAJay P Solgama, Edward Liu, Mellar Davis, et al.
Medical Teacher|March 24, 2016
Medical student perceptions of research and research-orientated careers: An international questionnaire studyGarth Funston, Rory J Piper, Claire Connell, et al.
Peerj|December 12, 2019
Dynamic changes in prescription opioids from 2006 to 2017 in TexasEbuwa O Ighodaro, Kenneth L McCall, Daniel Y Chung, et al.
Prostaglandins|February 1, 1980
Slow reacting substances (SRSs): the structure identification of SRSs from rat basophil leukaemia (RBL-1) cellsH R Morris, G W Taylor, P J Piper, et al.
British Journal of Clinical Pharmacology|December 1, 1990
Leukotrienes in the sputum and urine of cystic fibrosis childrenA P Sampson, D A Spencer, C P Green, et al.
Pharmacopsychiatry|July 31, 2024
Recreational Cannabis Legalization: No Contribution to Rising Prescription Stimulants in the USAGarrett D Alexander, Luke R Cavanah, Jessica L Goldhirsh, et al.
Pageof 68